Penetrating keratoplasty and glaucoma

Survey of Ophthalmology

Volumn 45, Issue 2, 2000, Pages 91-105

  Ayyala, Ramesh S ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Cyclodestructive procedures; Glaucoma; Glaucoma drainage devices; Mitomycin C; Penetrating keratoplasty; Post keratoplasty glaucoma; Trabeculectomy

Indexed keywords

ADRENALIN; ANTIGLAUCOMA AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CYCLOSPORIN A; DICLOFENAMIDE; DIPIVEFRINE; ECOTHIOPATE IODIDE; FLUOROURACIL; LATANOPROST; MIOTIC AGENT; MITOMYCIN C; PILOCARPINE; TIMOLOL MALEATE;

EYE TOXICITY; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; IMPLANT; INCIDENCE; LASER SURGERY; PATHOGENESIS; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TRABECULECTOMY;

EID: 0033799835     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(00)00141-7     Document Type: Article

References (119)

1. Krupin Eye Valve Filtering Surgery Study Group; Krupin eye valve with disk for filtration surgery. The Krupin Eye Valve Filtering Surgery Study Group
2. Late bleb-related endophthalmitis after trabeculectomy with mitomycin C
3. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group
4. Bleb infections; clinically different courses of blebitis and endophthalmitis
5. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes
6. Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty
7. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma
8. Modelling of changes in the corneal endothelium after cataract surgery and penetrating keratoplasty
9. Neodymium laser cyclocoagulation
10. The use of Molteno implant and anterior chamber tube shunt to encircling band for the treatment of glaucoma in keratoplasty patients
11. Cyclocryotherapy of chronic open-angle glaucoma in aphakic eyes
12. Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma
13. Carbonic anhydrase inhibitors
14. Surgical intervention on the ciliary body; new trends for the relief of glaucoma
15. Corneal endothelial changes in primary acute angle-closure glaucoma
16. Cyclocryotherapy for glaucoma after penetrating keratoplasty
17. Digital palpation of intraocular pressure
18. The effects of oversize donor buttons on postoperative intraocular pressure and corneal curvature in aphakic penetrating keratoplasty
19. The effect of mitomycin C on Molteno implant surgery; a 1-year randomized, masked, prospective study
20. Glaucoma in the immediate postoperative period after penetrating keratoplasty
21. Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty
22. Iridoplasty for prevention of post-keratoplasty angle closure and glaucoma
23. Neodymium:YAG laser transscleral cyclophotocoagulation for glaucoma after penetrating keratoplasty
24. The use of the Bausch and Lomb SOFLENS in tonometry
25. Human corneal thickness and its impact on intraocular pressure measures; a review and meta-analysis approach
26. Sympathetic ophthalmia following neodymium:YAG cyclotherapy
27. Applanation tonometry and central corneal thickness
28. Carbonic anhydrase inhibitor side effects. Serum chemical analysis
29. Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C
30. Focal scleral thinning after transscleral Nd:YAG cyclophotocoagulation
31. Glaucoma associated with penetrating keratoplasty
32. Glaucoma associated with penetrating keratoplasty
33. Drugs used primarily in ophthalmology
34. The management of post-keratoplasty glaucoma by trabeculectomy
35. Incidence of increased intraocular pressure after keratoplasty
36. Results of Neodymium; YAG laser transscleral cyclophotocoagulation for post-keratoplasty glaucoma
37. Semiconductor diode laser transscleral cyclophotocoagulation in patients with glaucoma
38. Ocular surface alteration after long-term treatment with an antiglaucomatous drug
39. 5-Fluorouracil and glaucoma filtering surgery. III. Intermediate follow-up of a pilot study
40. Goldmann applanation tonometry in patients with regular corneal astigmatism
41. Transscleral contact krypton laser cyclophotocoagulation for treatment of glaucoma
42. Penetrating keratoplasty with trabeculectomy
43. Intraolar pressure following penetrating keratoplasty
44. Intraolar pressure following penetrating keratoplasty
45. Factors associated with glaucoma after penetrating keratoplasty
46. Pressure measurement; which tonometer?
47. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit
48. Penetrating keratoplasty, glaucoma and silicone drainage tubing
49. The use of silicone drainage tubing to control post-keratoplasty glaucoma
50. Post-keratoplasty glaucoma
51. Coexistent corneal disease and glaucoma managed by either drainage surgery and subsequent keratoplasty or combined drainage surgery and penetrating keratoplasty
52. Serious corneal complications of glaucoma filtering surgery with postoperative 5-fluorouracil
53. Irreversible corneal decompensation in patients treated with topical dorzolamide
54. Timolol therapy in secondary angle-closure glaucoma post penetrating keratoplasty
55. The effect of adjunctive mitomycin C in Molteno implant surgery
56. Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids
57. The effect of intraocular surgery on clear corneal grafts
58. Transscleral YAG cyclocoagulation of the ciliary body for persistently high intraocular pressure following penetrating keratoplasty
59. Epinephrine-induced cystoid macular edema in aphakic eyes
60. Delayed corneal epitheliopathy after antimetabolite-augmented trabeculectomy
61. Corneal endothelial cell counts after Molteno implantation
62. Molteno implant for control of glaucoma in eyes after penetrating keratoplasty
63. Comparison of MacKay-Marg, Goldmann, and Perkins tonometers in abnormal corneas
64. New implant for drainage in glaucoma. Clinical trial
65. The use of draining implants in resistant cases of glaucoma
66. Human corneal endothelial cell density after an in vitro imitation of elevated intraocular pressure
67. The Goldmann applanation tonometer
68. Advanced uncontrolled glaucoma. Nd:YAG cyclophotocoagulation or tube surgery
69. Change in intraocular pressure during long-term use of loteprednol etabonate
70. The endothelial cell damage in acute glaucoma. On the corneal thickness response to intraocular pressure
71. A mathematical description of causative factors and prevention of elevated intraocular pressure after keratoplasty
72. Corneal sensation in acute angle-closure glaucoma
73. Adjunctive mitomycin C in Molteno implant surgery
74. Molteno implant with mitomycin C; intermediate-term results
75. Disparate diameter grafting. Astigmatism, intraocular pressure, and visual acuity
76. Topical cyclosporin A in the management of postkeratoplasty glaucoma
77. Results of alloplastic tube shunt procedures before, during, or after penetrating keratoplasty
78. The influence of glaucoma history on graft survival after penetrating keratoplasty
79. Questions concerning the role of apraclonidine in the management of glaucoma
80. Accuracy and precision of the Tono Pen in measuring IOP after keratoplasty and epikeratophakia and on scarred corneas
81. The accuracy of finger tension for estimating intraocular pressure after penetrating keratoplasty
82. The use of the Goldmann applanation tonometer
83. Post-penetrating keratoplasty glaucoma
84. Corneal endothelial cell density after an attack of acute glaucoma
85. Drainage tube implants in the treatment of glaucoma following penetrating keratoplasty
86. Noncontact transscleral Nd:YAG cyclophotocoagulation; a long-term follow-up of 500 patients
87. Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy
88. Long-term efficacy of argon laser trabeculoplasty
89. Clinical experience with the Baerveldt glaucoma drainage implant
90. Elevated intraocular pressure following penetrating keratoplasty
91. Intraoperative mitomycin versus postoperative 5-fluorouracil in high- risk glaucoma filtering surgery
92. The effect of glaucoma filtering surgery on corneal endothelial cell density
93. Ocular hazards of transscleral laser radiation. I. Spectral reflection and transmission of the sclera, choroid and retina
94. Dellen associated with filtering blebs
95. Cyclodiode; results of a standard protocol
96. Intraocular pressure response to topically administered fluorometholone
97. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group
98. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group
99. Mitomycin C as adjunctive therapy with glaucoma implant surgery
100. Effects of artificial intraocular pressure elevation on the corneal endothelium in the vervet monkey (Cercopithecus ethiops)
101. Noncontact transscleral Nd:YAG cyclophotocoagulation for glaucoma after penetrating keratoplasty
102. Follow-up of the original cohort with the Ahmed glaucoma valve implant
103. Laser trabeculoplasty for glaucoma in aphakic and pseudophakic eyes after penetrating keratoplasty
104. Latanoprost and herpes simplex keratitis
105. Dental mirror for goniosynechialysis during penetrating keratoplasty
106. Measurement of intraocular pressure with a pneumatic applanation tonometer
107. Cystoid macular edema following aphakic keratoplasty
108. Cyclocryotherapy for glaucoma pre- or postpenetrating keratoplasty
109. Treatment of glaucoma following penetrating keratoplasty with transscleral YAG cyclophotocoagulation
110. Graft failure after penetrating keratoplasty
111. Diode laser contact transscleral cyclophotocoagulation for refractory glaucoma in Asian patients
112. Combined penetrating keratoplasty and trabeculectomy with mitomycin C
113. Risk factors for graft failure in penetrating keratoplasty
114. A clinical comparison of transscleral cyclophotocoagulation with neodymium; YAG and semiconductor diode lasers
115. Assessment of corneal decompensation in eyes having undergone molteno shunt procedures compared to eyes having undergone trabeculectomy
116. Transplant size and elevated intraocular pressure
117. Side effects of timolol
118. The effect of suture depth on outflow facility in penetrating keratoplasty